A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.

Presently, human collagen VI-related diseases such as Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) remain incurable, emphasizing the need to unravel their etiology and improve their treatments. In UCMD, symptom onset occurs early, and both diseases aggravate with ageing. In...

Full description

Bibliographic Details
Main Authors: Zlatko Radev, Jean-Michel Hermel, Yannick Elipot, Sandrine Bretaud, Sylvain Arnould, Philippe Duchateau, Florence Ruggiero, Jean-Stéphane Joly, Frédéric Sohm
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4519248?pdf=render
_version_ 1818935437870235648
author Zlatko Radev
Jean-Michel Hermel
Yannick Elipot
Sandrine Bretaud
Sylvain Arnould
Philippe Duchateau
Florence Ruggiero
Jean-Stéphane Joly
Frédéric Sohm
author_facet Zlatko Radev
Jean-Michel Hermel
Yannick Elipot
Sandrine Bretaud
Sylvain Arnould
Philippe Duchateau
Florence Ruggiero
Jean-Stéphane Joly
Frédéric Sohm
author_sort Zlatko Radev
collection DOAJ
description Presently, human collagen VI-related diseases such as Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) remain incurable, emphasizing the need to unravel their etiology and improve their treatments. In UCMD, symptom onset occurs early, and both diseases aggravate with ageing. In zebrafish fry, morpholinos reproduced early UCMD and BM symptoms but did not allow to study the late phenotype. Here, we produced the first zebrafish line with the human mutation frequently found in collagen VI-related disorders such as UCMD and BM. We used a transcription activator-like effector nuclease (TALEN) to design the col6a1ama605003-line with a mutation within an essential splice donor site, in intron 14 of the col6a1 gene, which provoke an in-frame skipping of exon 14 in the processed mRNA. This mutation at a splice donor site is the first example of a template-independent modification of splicing induced in zebrafish using a targetable nuclease. This technique is readily expandable to other organisms and can be instrumental in other disease studies. Histological and ultrastructural analyzes of homozygous and heterozygous mutant fry and 3 months post-fertilization (mpf) fish revealed co-dominantly inherited abnormal myofibers with disorganized myofibrils, enlarged sarcoplasmic reticulum, altered mitochondria and misaligned sarcomeres. Locomotion analyzes showed hypoxia-response behavior in 9 mpf col6a1 mutant unseen in 3 mpf fish. These symptoms worsened with ageing as described in patients with collagen VI deficiency. Thus, the col6a1ama605003-line is the first adult zebrafish model of collagen VI-related diseases; it will be instrumental both for basic research and drug discovery assays focusing on this type of disorders.
first_indexed 2024-12-20T05:20:10Z
format Article
id doaj.art-ce4295a9f647413eb8f1002b4a8b0745
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T05:20:10Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ce4295a9f647413eb8f1002b4a8b07452022-12-21T19:52:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013398610.1371/journal.pone.0133986A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.Zlatko RadevJean-Michel HermelYannick ElipotSandrine BretaudSylvain ArnouldPhilippe DuchateauFlorence RuggieroJean-Stéphane JolyFrédéric SohmPresently, human collagen VI-related diseases such as Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) remain incurable, emphasizing the need to unravel their etiology and improve their treatments. In UCMD, symptom onset occurs early, and both diseases aggravate with ageing. In zebrafish fry, morpholinos reproduced early UCMD and BM symptoms but did not allow to study the late phenotype. Here, we produced the first zebrafish line with the human mutation frequently found in collagen VI-related disorders such as UCMD and BM. We used a transcription activator-like effector nuclease (TALEN) to design the col6a1ama605003-line with a mutation within an essential splice donor site, in intron 14 of the col6a1 gene, which provoke an in-frame skipping of exon 14 in the processed mRNA. This mutation at a splice donor site is the first example of a template-independent modification of splicing induced in zebrafish using a targetable nuclease. This technique is readily expandable to other organisms and can be instrumental in other disease studies. Histological and ultrastructural analyzes of homozygous and heterozygous mutant fry and 3 months post-fertilization (mpf) fish revealed co-dominantly inherited abnormal myofibers with disorganized myofibrils, enlarged sarcoplasmic reticulum, altered mitochondria and misaligned sarcomeres. Locomotion analyzes showed hypoxia-response behavior in 9 mpf col6a1 mutant unseen in 3 mpf fish. These symptoms worsened with ageing as described in patients with collagen VI deficiency. Thus, the col6a1ama605003-line is the first adult zebrafish model of collagen VI-related diseases; it will be instrumental both for basic research and drug discovery assays focusing on this type of disorders.http://europepmc.org/articles/PMC4519248?pdf=render
spellingShingle Zlatko Radev
Jean-Michel Hermel
Yannick Elipot
Sandrine Bretaud
Sylvain Arnould
Philippe Duchateau
Florence Ruggiero
Jean-Stéphane Joly
Frédéric Sohm
A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.
PLoS ONE
title A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.
title_full A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.
title_fullStr A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.
title_full_unstemmed A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.
title_short A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.
title_sort talen exon skipping design for a bethlem myopathy model in zebrafish
url http://europepmc.org/articles/PMC4519248?pdf=render
work_keys_str_mv AT zlatkoradev atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT jeanmichelhermel atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT yannickelipot atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT sandrinebretaud atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT sylvainarnould atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT philippeduchateau atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT florenceruggiero atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT jeanstephanejoly atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT fredericsohm atalenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT zlatkoradev talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT jeanmichelhermel talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT yannickelipot talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT sandrinebretaud talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT sylvainarnould talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT philippeduchateau talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT florenceruggiero talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT jeanstephanejoly talenexonskippingdesignforabethlemmyopathymodelinzebrafish
AT fredericsohm talenexonskippingdesignforabethlemmyopathymodelinzebrafish